Shield Therapeutics raises €8.2 million in Series A round

Shield Therapeutics, a Switzerland-based speciality pharmaceutical company, has raised €8.2 million in a Series A financing round from Inventages Venture Capital in order to help fund the late-stage development of a product for anaemia.